Martin Steinhart, CEO of AOP Health. Supraventricular tachycardias (including atrial fibrillation and atrial flutter) can ...

The first-in-human trial is taking place at Na Homolce hospital in Prague, Czechia, and will treat up to 50 patients.

The long-standing debate as to when to start anticoagulation in patients with an acute ischemic stroke and atrial fibrillation looks as though it is settled. Medscape Medical News, October 25 ...

Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am. Heart J. 159 , 857 ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

On Mondays, they saw a spike in patients presenting to emergency departments after a weekend of binge drinking with a heart condition called atrial fibrillation, which is characterised by an ...

Ortega-Martorell, S, Olier, I, Ohlsson, M and Lip, GYH (2024) Advancing personalised care in atrial fibrillation and stroke: the potential impact of AI from prevention to rehabilitation. Trends in ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation ... have already suffered an acute non-cardioembolic ischaemic ...

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today ...

Major Factors Driving the Growth of Direct Thrombin Inhibitors Market: ...